A detailed history of Stephens Investment Management Group LLC transactions in Dexcom Inc stock. As of the latest transaction made, Stephens Investment Management Group LLC holds 684,485 shares of DXCM stock, worth $51.9 Million. This represents 0.65% of its overall portfolio holdings.

Number of Shares
684,485
Previous 665,206 2.9%
Holding current value
$51.9 Million
Previous $75.4 Million 39.18%
% of portfolio
0.65%
Previous 1.09%

Shares

30 transactions
Quarter Operation Price Per share shares change shares Held SEC Form
Q3 2024

Oct 28, 2024

BUY
$64.0 - $116.06 $1.23 Million - $2.24 Million
19,279 Added 2.9%
684,485 $45.9 Million
Q2 2024

Aug 06, 2024

BUY
$110.31 - $140.45 $3.93 Million - $5 Million
35,625 Added 5.66%
665,206 $75.4 Million
Q1 2024

May 14, 2024

BUY
$114.22 - $140.1 $416,560 - $510,944
3,647 Added 0.58%
629,581 $87.3 Million
Q4 2023

Feb 13, 2024

SELL
$75.49 - $124.16 $355,784 - $585,166
-4,713 Reduced 0.75%
625,934 $77.7 Million
Q3 2023

Nov 14, 2023

BUY
$86.06 - $137.93 $681,423 - $1.09 Million
7,918 Added 1.27%
630,647 $58.8 Million
Q2 2023

Aug 14, 2023

BUY
$112.47 - $130.98 $990,410 - $1.15 Million
8,806 Added 1.43%
622,729 $80 Million
Q1 2023

May 15, 2023

BUY
$104.0 - $122.92 $68,744 - $81,250
661 Added 0.11%
613,923 $71.3 Million
Q4 2022

Jan 26, 2023

BUY
$84.98 - $122.67 $123,815 - $178,730
1,457 Added 0.24%
613,262 $68.7 Million
Q3 2022

Nov 07, 2022

BUY
$76.35 - $94.18 $2.72 Million - $3.35 Million
35,592 Added 6.18%
611,805 $49.3 Million
Q2 2022

Aug 03, 2022

BUY
$67.99 - $132.89 $29.4 Million - $57.4 Million
431,768 Added 298.92%
576,213 $42.9 Million
Q1 2022

May 04, 2022

BUY
$94.08 - $130.2 $256,744 - $355,315
2,729 Added 1.93%
144,445 $73.9 Million
Q4 2021

Feb 15, 2022

SELL
$129.87 - $162.82 $4.04 Million - $5.07 Million
-31,112 Reduced 18.0%
141,716 $76.1 Million
Q3 2021

Oct 27, 2021

SELL
$106.71 - $143.18 $610,487 - $819,132
-5,721 Reduced 3.2%
172,828 $94.5 Million
Q2 2021

Aug 09, 2021

SELL
$80.99 - $107.93 $117,273 - $156,282
-1,448 Reduced 0.8%
178,549 $76.2 Million
Q1 2021

May 14, 2021

BUY
$84.79 - $104.74 $277,008 - $342,185
3,267 Added 1.85%
179,997 $64.7 Million
Q4 2020

Feb 10, 2021

SELL
$78.0 - $104.5 $1.25 Million - $1.67 Million
-16,010 Reduced 8.31%
176,730 $65.3 Million
Q3 2020

Nov 13, 2020

SELL
$95.51 - $112.95 $2.3 Million - $2.72 Million
-24,051 Reduced 11.09%
192,740 $79.5 Million
Q2 2020

Aug 24, 2020

SELL
$62.68 - $105.34 $3.07 Million - $5.16 Million
-48,991 Reduced 18.43%
216,791 $87.9 Million
Q1 2020

May 14, 2020

SELL
$47.79 - $75.63 $853,863 - $1.35 Million
-17,867 Reduced 6.3%
265,782 $71.6 Million
Q4 2019

Feb 14, 2020

SELL
$36.62 - $57.29 $537,654 - $841,131
-14,682 Reduced 4.92%
283,649 $62 Million
Q3 2019

Oct 18, 2019

BUY
$35.53 - $43.8 $283,422 - $349,392
7,977 Added 2.75%
298,331 $44.5 Million
Q2 2019

Aug 01, 2019

BUY
$27.84 - $38.92 $417,794 - $584,072
15,007 Added 5.45%
290,354 $43.5 Million
Q1 2019

May 03, 2019

SELL
$28.07 - $38.18 $421,667 - $573,539
-15,022 Reduced 5.17%
275,347 $32.8 Million
Q4 2018

Feb 11, 2019

SELL
$26.99 - $37.37 $457,669 - $633,683
-16,957 Reduced 5.52%
290,369 $34.8 Million
Q3 2018

Nov 14, 2018

SELL
$23.35 - $36.72 $303,176 - $476,772
-12,984 Reduced 4.05%
307,326 $44 Million
Q2 2018

Aug 10, 2018

BUY
$17.54 - $25.22 $49,989 - $71,877
2,850 Added 0.9%
320,310 $30.2 Million
Q1 2018

May 04, 2018

BUY
$13.06 - $18.54 $626,213 - $888,974
47,949 Added 17.79%
317,460 $23.5 Million
Q4 2017

Feb 05, 2018

BUY
$11.12 - $15.38 $858,319 - $1.19 Million
77,187 Added 40.13%
269,511 $15.5 Million
Q3 2017

Nov 08, 2017

BUY
$11.36 - $18.98 $1.76 Million - $2.93 Million
154,596 Added 409.76%
192,324 $9.41 Million
Q2 2017

Aug 10, 2017

BUY
N/A
37,728
37,728 $2.76 Million

Others Institutions Holding DXCM

About DEXCOM INC


  • Ticker DXCM
  • Exchange NASDAQ
  • Sector Healthcare
  • Industry Medical Devices
  • Shares Outstandng 386,257,984
  • Market Cap $29.3B
  • Description
  • DexCom, Inc., a medical device company, focuses on the design, development, and commercialization of continuous glucose monitoring (CGM) systems in the United States and internationally. The company provides its systems for use by people with diabetes, as well as for use by healthcare providers. Its products include DexCom G6, an integrated CGM ...
More about DXCM
Track This Portfolio

Track Stephens Investment Management Group LLC Portfolio

Follow Stephens Investment Management Group LLC and customize your updates to receive the information that matters most to you.

Portfolio Update

Get notified when there are updates to the investment portfolio of Stephens Investment Management Group LLC, based on Form 13F filings with the SEC.

News

Stay updated on Stephens Investment Management Group LLC with notifications on news.